DYN

Dyne Therapeutics, Inc.

• Simply Wall St·10/13 11:28

  Can One Year DM1 Data Change The Bull Case For Dyne Therapeutics Stock?

• NASDAQ·10/12 20:55

  Oversold Conditions For Dyne Therapeutics (DYN)

• Benzinga·10/09 12:05

  12 Health Care Stocks Moving In Friday's Pre-Market Session

• Simply Wall St·10/07 10:27

  Dyne Therapeutics (DYN) After Fresh ACHIEVE Data With Undervalued Narrative Intact

• Simply Wall St·10/06 03:26

  Does One Year DM1 Trial Data Change The Bull Case For Dyne Therapeutics Stock?

• NASDAQ·10/01 19:25

  Noteworthy Thursday Option Activity: WULF, DYN, ASTS

• Seeking Alpha·10/01 11:44

  These ten healthcare stocks posted the biggest one-month losses

• Seeking Alpha·09/30 17:30

  Dyne: Recent Price Drop On Rival's DM1 Data Creates (Risky) 'Buy The Dip' Scenario

• TipRanks·09/30 13:15

  Dyne Therapeutics: Growing Clinical Evidence for z-basivarsen Supports Outperform/Buy Rating and Maintained $40 Price Target

• TipRanks·09/30 12:40

  Analysts Offer Insights on Healthcare Companies: Medios AG (OtherMEDOF) and Dyne Therapeutics (DYN)

• Dow Jones·09/30 12:10

  Dyne Therapeutics Price Target Maintained With a $38.00/Share by Chardan Capital

• Dow Jones·09/30 12:10

  Dyne Therapeutics Is Maintained at Buy by Chardan Capital

• Dow Jones·09/30 10:28

  Dyne Therapeutics Price Target Cut to $32.00/Share From $50.00 by HC Wainwright & Co.

• Dow Jones·09/30 10:28

  Dyne Therapeutics Is Maintained at Buy by HC Wainwright & Co.

• Benzinga·09/30 10:18

  HC Wainwright & Co. Maintains Buy on Dyne Therapeutics, Lowers Price Target to $32